Condition
Arthrogenic Muscle Inhibitions
Total Trials
2
Recruiting
0
Active
0
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 2 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
2Total
Not Applicable (2)
Trial Status
Unknown1
Enrolling By Invitation1
Clinical Trials (2)
Showing 2 of 2 trials
NCT06774157Not ApplicableEnrolling By Invitation
Evaluation of the Efficacy of the ALLYANE Procedure in the Treatment of Central Motor Inhibition
NCT06000345Not ApplicableUnknown
Effect of Action Observation and Motor Imagery on Arthrogenic Muscle Inhibition of the Quadriceps in Patients With End-stage Knee Gonarthrosis.
Showing all 2 trials